Eli Lilly Leads GLP-1 Rivals
This is a news story, published by CNBC, that relates primarily to Evan Seigerman news.
Evan Seigerman news
For more Evan Seigerman news, you can click here:
more Evan Seigerman newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
blockbuster diabetes drug Ozempic. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Eli Lilly shares news, diabetes drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Novo NordiskCNBC
•Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
88% Informative
" Lilly is pulling ahead in the metabolic duopoly," BMO Capital Markets analyst Evan Seigerman said.
Eli Lilly's weight loss injection Zepbound and diabetes treatment Mounjaro smashed expectations for the second quarter .
Novo Nordisk trimmed its full-year profit outlook after sales of Wegovy came in well below Wall Street expectations.
Stryker says the acquisition is subject to customary closing conditions.
Terms of the deal were not disclosed.
"Our commitment to simplifying and enhancing the lives of healthcare professionals and patients remains unwavering," CEO Chakri Toleti says.
The technology Care.ai offers will "integrate seamlessly" with Strykers ' platforms and devices, company says.
VR Score
91
Informative language
93
Neutral language
47
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
4
Affiliate links
no affiliate links